• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    In this June 14, 2011 photo, the blood thinner medication Plavix is displayed at Medco Health Solutions Inc., in Willingboro, N.J.  The cost of prescription medicines used by millions of people every day is about to plummet.The next 15 months will bring generic versions of seven of the world's 20 best-selling drugs, including the top two: cholesterol fighter Lipitor and blood thinner Plavix.
    Healthcare

    Medicare could have saved nearly $1 billion by using generics, study finds

    Robert King -
    August 21, 2018 9:51 pm
    0
    Merck CEO Kenneth Frazier listens as President Trump speaks during a meeting with pharmaceutical industry leaders.
    Business

    Pharma industry sales climb despite Trump’s pressure on prices

    Joe Williams -
    August 21, 2018 6:15 pm
    0
    The opioid epidemic is a cultural problem, it requires cultural solutions
    Healthcare

    The opioid epidemic is a cultural problem, it requires cultural solutions

    Ericka Andersen -
    August 21, 2018 12:00 am
    0
    President Donald Trump speaks during an event about prescription drug prices with Health and Human Services Secretary Alex Azar in the Rose Garden of the White House in Washington, Friday, May 11, 2018.
    Healthcare

    Trump administration says its drug blueprint has already lowered prices

    Robert King -
    August 20, 2018 8:40 pm
    0
    A pharmacist holds a package of EpiPen epinephrine auto-injectors.
    Healthcare

    FDA approves first generic competitor for EpiPen

    Robert King -
    August 16, 2018 7:19 pm
    0
    President Trump this week slammed Attorney General Jeff Sessions for asking the Justice Department's Office of Inspector General to investigate alleged abuses of the Foreign Intelligence Surveillance Act. (AP Photo/Evan Vucci, File)
    Healthcare

    Trump urges federal lawsuit against opioid manufacturers

    Melissa Quinn -
    August 16, 2018 5:16 pm
    0
    Drug middlemen push back that rebates are to blame for high drug prices
    Healthcare

    Drug middlemen push back that rebates are to blame for high drug prices

    Robert King -
    August 15, 2018 5:26 pm
    0
    Syringes of the opioid painkiller fentanyl are pictured in an inpatient pharmacy.
    Beltway Confidential

    Drug companies opposed to the death penalty have changed executions

    Erin Dunne -
    August 14, 2018 10:11 pm
    0
    FILE- In this June 1, 2018 file photo, small vials of fentanyl are shown in the inpatient pharmacy at the University of Utah Hospital in Salt Lake City. Nebraska state officials are preparing for their first execution in two decades on Aug. 14 at the Nebraska State Penitentiary in Lincoln, Neb., and their first-ever lethal injection with an untried combination of drugs. The new execution protocol calls for an initial IV dose of diazepam, commonly known as Valium, to render the inmate unconscious; the powerful synthetic opioid fentanyl; cisatracurium besylate to induce paralysis and stop the inmate from breathing; and potassium chloride to stop the heart.
    Healthcare

    Nebraska the first to use fentanyl to carry out death penalty

    Kimberly Leonard -
    August 14, 2018 5:10 pm
    0
    Carl Icahn, billionaire activist investor, waits for Donald Trump, president and chief executive of Trump Organization Inc. and 2016 Republican presidential candidate, not pictured, to speak at an election night event in New York, U.S., on Tuesday, April 19, 2016. Trump, the billionaire real-estate mogul, got a major boost in his quest to secure the Republican nomination with a majority of delegates but could not eliminate the possibility of a contested convention.
    Business

    Carl Icahn drops opposition to Express Scripts-Cigna merger

    Robert King -
    August 14, 2018 4:04 pm
    0
    1...787980...160Page 79 of 160
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.